Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2941
Selected: 0
NCT IDTitle
NCT02461602Eliminate Thromboembolism: Improving Anticoagulation in Non-valvular Atrial Fibrillation Patients
NCT00435669A Phase I Study to Determine Absorption, Distribution, Metabolism, and Elimination of a Single Radiolabeled Dose of Brivanib (BMS-582664)
NCT00313300Safety Study of Apixaban in Recent Acute Coronary Syndrome
NCT04272333Intratumoral Microdosing of Motolimod in HNSCC
NCT00924898Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
NCT00134706A Study of Docetaxel Plus Carboplatin in Patients With Hormone Refractory Prostate Cancer
NCT00135434Effect of HIV Protease Inhibitor Drugs on Glucose and Insulin Metabolism
NCT03168464Radiation and Immune Checkpoints Blockade in Metastatic NSCLC (BMS # CA209-632)
NCT03642067Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
NCT03141177A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
NCT01472081Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)
NCT04817007A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)
NCT03770299An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease
NCT00731367Comparative Evaluation of Two AQUACEL Ag Protocols of Care for the Management of Donor Sites
NCT02045693Drug Interaction & Methadone & Buprenorphine
NCT04065932A Study to Determine the Pharmacokinetic Profile of BMS-986165 Tablets
NCT02159365Study of Safety of Elotuzumab Administered Over Approximately 60 Minutes in Combination With Lenalidomide and Dexamethasone for Newly Diagnosed or Relapsed/Refractory Multiple Myeloma Patients
NCT05980949Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
NCT06855771A Study of Navlimetostat (BMS-986504) Alone or in Combination With Izalontamab Brengitecan in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion or MTAP Loss (MountainTAP-9)
NCT00289263Maintenance Chemotherapy in Metastatic Breast Cancer
NCT02098616Rapid Hepatitis C Elimination Trial- A Pilot Study of Daclatasvir/Asunaprevir/BMS-791325 With or Without Ribavirin To Treat Hepatitis C Virus
NCT00350038Irbesartan, Ciprofibrate and Their Combination Onto the Endothelial Functions
NCT00493779A Study to Evaluate the Discontinuation Effect of Clopidogrel After Drug Eluting Stent Implantation in Non-diabetic Patients
NCT02617589An Investigational Immuno-therapy Study of Nivolumab Compared to Temozolomide, Each Given With Radiation Therapy, for Newly-diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer)
NCT00389155First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy
NCT02829918Study of Nivolumab in Patients With Advanced Refractory Biliary Tract Cancers
NCT03785925A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer
NCT01055691A Study Comparing the Amount of Metformin and After Taking a Combination Tablet vs. Separate Tablets
NCT00295282A Dose-Escalation Study of MDX-1100 in Patients With Active Ulcerative Colitis
NCT00382668A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug
NCT04021108Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L)
NCT05638282A Study to Evaluate the Safety and Tolerability of Cendakimab in Chinese Healthy Participants
NCT02856646Hodgkin Lymphoma Molecular Profiling and Clinical Outcomes in U.S. Community Oncology Practices
NCT06999980Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
NCT07783373Long-Term Real-World Safety of Cobenfy in Adults With Schizophrenia
NCT00337805Double Blind Randomized Trial of Saline vs Pentaspan for Resuscitation After Cardiac Surgery
NCT02865369Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
NCT02095860Food Effect of a Fixed Dose Combination of Daclatasvir, Asunaprevir and BMS-791325
NCT00908024Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors
NCT03382496Observational Study for Lung Cancer Patients Treated With Nivolumab
NCT00000686A Study of d4T in Patients With AIDS or AIDS-Related Complex Who Cannot Take AZT
NCT01835470Efficacy, Safety, Pharmacokinetics and Immunogenicity Study of Abatacept Administered Intravenously to Treat Active Polyarticular-course Juvenile Idiopathic Arthritis in Japan
NCT00135408A Study of MDX-010 (BMS-734016) Administered With or Without Prophylactic Oral Budesonide
NCT03420768A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C
NCT03867916Patient Portal and Navigation Program in Providing Information for Asian American Cancer Patients
NCT00344552Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer
NCT00231348Nefazodone in the Treatment of Social Phobia
NCT03805178Lung Transplant Plasmapheresis/Belatacept/Carfilzomib for Antibody Mediated Rejection and Desensitization
NCT06247540Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
NCT01931150Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT